Structures by: Thiruvalluvar A.
Total: 151
Thiopyran-4-one 1-oxide
C17H15ClO2S
Acta Crystallographica Section E (2008) 64, 12 o2367
a=11.5195(5)Å b=25.7589(12)Å c=5.2248(2)Å
α=90° β=90° γ=90°
Dihydropyrimidine-2(1H)-thione
C13H13ClN2OS
Acta Crystallographica Section E (2009) 65, 3 o564-o565
a=7.2389(6)Å b=8.2304(7)Å c=12.9038(11)Å
α=73.366(7)° β=89.373(7)° γ=72.613(7)°
1H-imidazole
C25H16N4
Acta Crystallographica Section E (2011) 67, 4 o989
a=8.8693(7)Å b=10.0637(6)Å c=11.8960(9)Å
α=100.219(6)° β=110.310(7)° γ=102.475(6)°
Carbazole
C13H13NO
Acta Crystallographica Section E (2010) 66, 9 o2299-o2300
a=10.5245(2)Å b=7.15640(10)Å c=13.5870(3)Å
α=90° β=93.960(2)° γ=90°
Dihydropyrimidinone
C14H16N2O3
Acta Crystallographica Section E (2009) 65, 1 o23
a=23.7948(12)Å b=7.9905(3)Å c=14.4757(7)Å
α=90° β=108.305(5)° γ=90°
Carbazole
C15H13NO2
Acta Crystallographica Section E (2010) 66, 12 o3146
a=7.4602(2)Å b=12.7353(3)Å c=24.9325(5)Å
α=90° β=92.319(2)° γ=90°
Carbazole
C15H11N3
Acta Crystallographica Section E (2010) 66, 7 o1713
a=8.4794(3)Å b=10.5542(4)Å c=13.0575(5)Å
α=90° β=97.366(3)° γ=90°
Piperidin-4-one
C22H19NOS2
Acta Crystallographica Section E (2011) 67, 3 o571
a=6.1809(3)Å b=12.7391(9)Å c=12.9251(7)Å
α=112.657(6)° β=95.845(5)° γ=98.512(5)°
Piperidin-4-one
C21H25NO
Acta Crystallographica Section E (2009) 65, 10 o2445
a=12.9576(3)Å b=22.6153(5)Å c=5.96000(10)Å
α=90° β=90° γ=90°
Pyrazoline
C16H13Cl2FN2OS
Acta Crystallographica Section E (2008) 64, 11 o2160
a=7.2240(5)Å b=8.8642(4)Å c=14.0518(9)Å
α=100.794(5)° β=103.307(6)° γ=101.003(5)°
4-[5-Methyl-4-(morpholin-4-ylcarbonyl)-1<i>H</i>-1,2,3-triazol-1-yl]- 8-(trifluoromethyl)quinoline
C18H16F3N5O2
Acta Crystallographica Section E (2008) 64, 12 o2375
a=9.2836(15)Å b=9.6164(11)Å c=9.9272(11)Å
α=92.082(9)° β=93.063(11)° γ=105.728(12)°
Dihydropyrimidinone
C13H13ClN2O2
Acta Crystallographica Section E (2008) 64, 12 o2474-o2475
a=14.5364(8)Å b=12.1587(5)Å c=7.0780(4)Å
α=90° β=90° γ=90°
Piperidin-4-one
C21H25NO3
Acta Crystallographica Section E (2008) 64, 12 o2328
a=5.9772(2)Å b=23.0858(8)Å c=26.7611(8)Å
α=90° β=93.543(3)° γ=90°
Triphenylpyrazine
C22H16N2
Acta Crystallographica Section E (2009) 65, 1 o106
a=15.563(2)Å b=6.2005(9)Å c=16.845(3)Å
α=90° β=90° γ=90°
Cyclohex-2-enone
C21H19ClO3
Acta Crystallographica Section E (2009) 65, 1 o191
a=8.0115(3)Å b=11.3525(4)Å c=11.6386(4)Å
α=62.261(2)° β=77.975(2)° γ=75.297(2)°
Nicotinohydrazide
C16H15N3O,H2O
Acta Crystallographica Section E (2009) 65, 7 o1659
a=9.6821(4)Å b=9.4178(4)Å c=16.0958(6)Å
α=90° β=98.250(4)° γ=90°
Carbazolone
C13H13NO
Acta Crystallographica Section E (2009) 65, 8 o1946-o1947
a=5.8301(3)Å b=8.4348(5)Å c=10.8000(7)Å
α=78.094(5)° β=75.942(5)° γ=87.166(5)°
Piperidin-4-one
C21H23NO4
Acta Crystallographica Section E (2009) 65, 11 o2813
a=11.5409(4)Å b=12.4972(5)Å c=14.7816(6)Å
α=67.878(4)° β=74.719(3)° γ=67.123(4)°
Nicotinohydrazide
C15H13N3O,H2O
Acta Crystallographica Section E (2009) 65, 11 o2833
a=9.8456(3)Å b=9.1288(3)Å c=15.5389(5)Å
α=90° β=95.938(3)° γ=90°
1,4-diphenylbutadienylcyanide
C17H13N
Acta Crystallographica Section E (2009) 65, 11 o2953
a=16.9390(5)Å b=7.5869(2)Å c=19.3809(6)Å
α=90° β=99.521(3)° γ=90°
Hydrazine
C26H18N2
Acta Crystallographica Section E (2010) 66, 2 o345
a=22.8362(3)Å b=13.1432(2)Å c=12.4642(2)Å
α=90° β=92.8740(10)° γ=90°
Hydrazine
C22H17N3
Acta Crystallographica Section E (2010) 66, 7 o1586
a=24.1594(3)Å b=13.8501(2)Å c=5.21730(10)Å
α=90° β=90° γ=90°
1H-imidazole
C18H17FN2
Acta Crystallographica Section E (2010) 66, 7 o1703
a=9.8888(2)Å b=7.66930(10)Å c=20.1017(3)Å
α=90° β=95.9150(10)° γ=90°
1H-imidazole
C18H17FN2O
Acta Crystallographica Section E (2010) 66, 7 o1791
a=8.51320(10)Å b=9.5128(2)Å c=19.2610(3)Å
α=90° β=96.798(2)° γ=90°
Cyclohex-2-enone
C21H19BrO3
Acta Crystallographica Section E (2010) 66, 8 o1896
a=11.0138(2)Å b=13.8197(4)Å c=12.1477(3)Å
α=90° β=95.180(2)° γ=90°
Dihydropyrimidin-2(1H)-thione
C13H14N2OS
Acta Crystallographica Section E (2010) 66, 9 o2280
a=7.8849(10)Å b=7.2054(5)Å c=21.555(3)Å
α=90° β=94.401(12)° γ=90°
2,5-Dimethyl-7,8,9,10-tetrahydrocyclohepta[<i>b</i>]indol-6(5<i>H</i>)-one
C15H17NO
Acta Crystallographica Section E (2010) 66, 11 o2882
a=15.5889(3)Å b=10.5707(2)Å c=7.5388(2)Å
α=90° β=90° γ=90°
1H-imidazole
C19H20N2,0.5(H2O)
Acta Crystallographica Section E (2010) 66, 11 o2776
a=16.7611(2)Å b=11.5467(2)Å c=16.6563(2)Å
α=90° β=90° γ=90°
Piperidine
C25H26N4O
Acta Crystallographica Section E (2010) 66, 11 o2841
a=6.21280(10)Å b=12.8346(3)Å c=15.0022(3)Å
α=65.2930(10)° β=78.8230(10)° γ=86.9480(10)°
1H-imidazole
C18H18N2
Acta Crystallographica Section E (2010) 66, 11 o2826
a=9.6971(3)Å b=7.5458(2)Å c=19.8407(7)Å
α=90° β=96.604(3)° γ=90°
1H-imidazole
C27H19FN2
Acta Crystallographica Section E (2010) 66, 10 o2519
a=10.1794(5)Å b=10.5239(6)Å c=10.6175(6)Å
α=80.750(5)° β=85.776(4)° γ=67.348(5)°
1H-imidazole
C17H16N2,H2O
Acta Crystallographica Section E (2010) 66, 9 o2219
a=25.5498(2)Å b=25.5498(2)Å c=9.37920(10)Å
α=90° β=90° γ=90°
Carbazole
C17H12ClNO2
Acta Crystallographica Section E (2010) 66, 12 o3198
a=15.0985(2)Å b=6.15530(10)Å c=15.3887(2)Å
α=90° β=104.3190(10)° γ=90°
Carbazole
C18H15NO2
Acta Crystallographica Section E (2010) 66, 12 o3145
a=6.73530(10)Å b=16.1393(3)Å c=25.9549(4)Å
α=90° β=90° γ=90°
Carbazole
C13H13NS
Acta Crystallographica Section E (2011) 67, 7 o1642
a=7.0846(4)Å b=9.5287(7)Å c=9.6384(6)Å
α=115.009(7)° β=104.901(6)° γ=98.074(6)°
2-Chloro-7,8,9,10-tetrahydrocyclohepta[<i>b</i>]indol-6(5<i>H</i>)-one
C13H12ClNO
Acta Crystallographica Section E (2012) 68, 6 o1887
a=11.6354(4)Å b=6.3798(2)Å c=14.4513(5)Å
α=90° β=92.767(3)° γ=90°
1H-imidazole
C19H19FN2
Acta Crystallographica Section E (2011) 67, 5 o1065
a=8.4226(10)Å b=9.5572(10)Å c=11.0351(11)Å
α=105.423(9)° β=105.677(9)° γ=95.781(9)°
1-(3,5-Dimethoxyphenyl)-2-(4-fluorophenyl)-4,5-dimethyl-1<i>H</i>-imidazole
C19H19FN2O2
Acta Crystallographica Section E (2012) 68, 2 o256
a=6.96540(10)Å b=17.8520(3)Å c=13.7121(3)Å
α=90° β=97.833(2)° γ=90°
2,3-dihydropyrazine
C23H19ClN2
Acta Crystallographica Section E (2011) 67, 10 o2598
a=10.5675(8)Å b=19.7014(9)Å c=10.4207(7)Å
α=90° β=118.479(9)° γ=90°
5-Methyl-7,8,9,10-tetrahydrocyclohepta[<i>b</i>]indol-6(5<i>H</i>)-one
C14H15NO
Acta Crystallographica Section E (2011) 67, 6 o1325
a=8.6999(2)Å b=14.1805(3)Å c=9.1392(3)Å
α=90° β=90° γ=90°
9-Ethyl-<i>N</i>-(3-nitrobenzylidene)-9<i>H</i>-carbazol-3-amine
C21H17N3O2
Acta Crystallographica Section E (2011) 67, 7 o1799
a=8.1550(4)Å b=13.5093(7)Å c=16.0248(9)Å
α=90° β=103.899(5)° γ=90°
1H-imidazole
C25H15FN4,H2O
Acta Crystallographica Section E (2011) 67, 8 o1965
a=9.0103(10)Å b=10.0946(9)Å c=11.3994(9)Å
α=86.987(7)° β=75.950(8)° γ=82.396(8)°
Benzimidazole
C22H20N2
Acta Crystallographica Section E (2011) 67, 12 o3519
a=9.6610(2)Å b=10.2900(2)Å c=17.7271(3)Å
α=84.437(2)° β=81.536(2)° γ=76.165(2)°
Phenanthro[9,10-d]imidazole
C28H19FN2
Acta Crystallographica Section E (2012) 68, 10 o2880
a=10.1809(2)Å b=10.7654(2)Å c=18.4871(3)Å
α=90° β=96.1150(10)° γ=90°
2,3-dihydropyrazine
C24H22N2
Acta Crystallographica Section E (2012) 68, 11 o3084
a=8.1986(5)Å b=11.8211(6)Å c=19.6686(7)Å
α=90° β=93.638(4)° γ=90°
Benzimidazole
C19H13FN2
Acta Crystallographica Section E (2012) 68, 9 o2708
a=8.7527(4)Å b=10.1342(4)Å c=17.0211(6)Å
α=90° β=104.187(4)° γ=90°
Pyrazine
C24H20N2
Acta Crystallographica Section E (2012) 68, 10 o3003
a=9.2327(9)Å b=9.8708(11)Å c=10.6787(14)Å
α=79.604(10)° β=70.351(11)° γ=87.848(8)°
Dihydropyrimidin-2(1H)-thione
C13H13FN2OS
Acta Crystallographica Section E (2012) 68, 9 o2625
a=7.1775(11)Å b=8.1099(13)Å c=12.490(2)Å
α=103.529(15)° β=91.933(14)° γ=106.971(14)°
Dihydropyrimidin-2(1H)-thione
C16H20N2OS
Acta Crystallographica Section E (2012) 68, 9 o2641
a=26.8413(5)Å b=9.5657(2)Å c=12.0764(2)Å
α=90° β=90.370(2)° γ=90°
1H-benzimidazole
C19H14N2
Acta Crystallographica Section E (2012) 68, 12 o3283
a=10.1878(3)Å b=16.6399(4)Å c=17.4959(5)Å
α=90° β=106.205(3)° γ=90°
Benzimidazole
C23H16N2,0.5(C6H6)
Acta Crystallographica Section E (2014) 70, 1 o55-o56
a=8.5529(3)Å b=9.4517(3)Å c=11.8936(3)Å
α=86.334(2)° β=89.838(2)° γ=75.051(3)°